文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

横纹肌溶解症:内科10年回顾性研究

Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department.
PubMed 文献 · Eur J Emerg Med · 2019-01-01
一句话结论在内科治疗的横纹肌溶解症患者中,血清肌红蛋白浓度比肌酸激酶活性更能预测急性肾损伤,肌红蛋白/肌酸激酶比值大于0.2与急性肾损伤风险增加相关。

该研究为10年回顾性研究,纳入2003至2012年奥斯陆大学医院Ulleval内科收治的341例横纹肌溶解症患者,定义血清肌酸激酶活性超过正常参考上限5倍。51%发生急性肾损伤,其中20%需要透析。逻辑回归显示肌红蛋白浓度(P<0.001,OR=6.24)比肌酸激酶活性(P=0.001,OR=3.45)更能预测急性肾损伤,肌红蛋白/肌酸激酶比值也是良好预测指标(P<0.001,OR=5.97),比值大于0.2与急性肾损伤可能性增加相关。

要点

  • 在341例内科横纹肌溶解症患者中,51%发生急性肾损伤,其中20%需要透析。
  • 肌红蛋白浓度预测急性肾损伤的OR为6.24(P<0.001),优于肌酸激酶活性的OR=3.45(P=0.001)。
  • 肌红蛋白/肌酸激酶比值预测急性肾损伤的OR为5.97(P<0.001),比值大于0.2与急性肾损伤可能性增加相关。
  • 横纹肌溶解症定义为血清肌酸激酶活性超过正常参考上限5倍。

适用人群与场景

  • 2003至2012年在奥斯陆大学医院Ulleval内科治疗的横纹肌溶解症患者,定义为血清肌酸激酶活性超过正常参考上限5倍。

诊断标准与关键阈值

  • 横纹肌溶解症定义为血清肌酸激酶活性超过正常参考上限5倍。
  • 肌红蛋白/肌酸激酶比值大于0.2与急性肾损伤可能性增加相关。

研究设计与关键结果

  • 研究为10年回顾性研究,纳入341例在内科治疗的横纹肌溶解症患者。
  • 51%的患者发生急性肾损伤,其中20%需要透析。
  • 逻辑回归显示肌红蛋白浓度是急性肾损伤的预测因子(P<0.001,OR=6.24),肌酸激酶活性也是预测因子(P=0.001,OR=3.45)。
  • 肌红蛋白/肌酸激酶比值是急性肾损伤的良好预测指标(P<0.001,OR=5.97)。
  • 急性肾损伤风险随肌红蛋白/肌酸激酶比值增加而增加(P<0.001),比值大于0.2与急性肾损伤可能性增加相关。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血清肌红蛋白浓度是比血清肌酸激酶活性更好的急性肾损伤预测指标。
  • 作者认为肌红蛋白/肌酸激酶比值可能有助于评估发生急性肾损伤的可能性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Rhabdomyolysis is a common and potentially life-threatening syndrome, and acute kidney injury (AKI) is a serious complication. We performed a 10-year retrospective study that included all patients treated for rhabdomyolysis in a medical clinic. We examined the relationships between the levels of creatine kinase (CK), myoglobin, and creatinine (as a marker of renal function and thereby AKI), and whether the myoglobin/CK ratio could be a valuable tool in the clinical evaluation of this patient group. Clinical characteristics were noted.

PATIENTS AND METHODS: The study included all patients treated for rhabdomyolysis in the Department of Medicine, Oslo University Hospital Ulleval, from 2003 to 2012. Rhabdomyolysis was defined as a serum CK activity more than five times the upper reference limit.

RESULTS: A total of 341 patients were included in the study; 51% developed AKI, and 20% of those required dialysis. Logistic regression showed that myoglobin concentration [P < 0.001, odds ratio (OR) = 6.24] was a better predictor than CK activity (P = 0.001, OR = 3.45) of the development of AKI. The myoglobin/CK ratio was a good predictor of AKI (P < 0.001, OR = 5.97). The risk of developing AKI increased with increasing myoglobin/CK ratio (P < 0.001); a ratio more than 0.2 was associated with an increased likelihood of developing AKI.

CONCLUSION: Serum myoglobin concentration was a better predictor of AKI than was serum CK activity. The myoglobin/CK ratio may be useful for assessing the likelihood of developing AKI.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Vangstad M, Bjornaas MA, Jacobsen D, et al. Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department. Eur J Emerg Med. 2019. PMID: 29068810. doi:10.1097/MEJ.0000000000000510

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。